The balance between p53 and GLI1 activities appears to be critical: loss of p53 in cancer could enable activities of GLI1 and GLI232,33, while repression of GLI3 activity potentiates p53-dependent cell growth inhibition in colon cancer cells34. Here, TP53 is linked to cancer.